The European Commission on Monday said it has launched a legal action against vaccine maker AstraZeneca for failing to respect the terms of its contract with the EU.
Spokesman Stefan De Keersmaecker said, The Commission has started last Friday legal action against the company AstraZeneca on the basis of breaches of the advance purchase agreement.
He said that the reason for the legal action was that some terms of the contract have not been respected and that the company has not been in a position to come up with a reliable strategy to ensure a timely delivery of doses.
AstraZeneca's contract with the European Union foresaw an initial 300 million doses for distribution among the 27 member countries, with option for a further 100 million.
But only 30 million doses were delivered in the first quarter of 2021, and the company says it can only provide 70 million in the second quarter, rather than the 180 million it had promised.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)